NDC 83257-001 – Ogivri
Trastuzumab 150 mg/7.4mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC83257-001
Product details
- Brand name
- Ogivri
- Generic name
- Trastuzumab-dkst
- Labeler
- Biocon Biologics Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761074
- Marketed since
- October 1, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- HER2/neu Receptor Antagonist
Active ingredients
- Trastuzumab 150 mg/7.4mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83257-001-11 | 1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL | Oct 1, 2023 |